| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biorestorative Therapies, Inc. (BRTX) has 2 insiders with recent SEC Form 4 filings, including 14 buys and 3 sells. BRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 187.5K | $35.9K | - | |
| VP | 171.4K | $32.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2024 | Broadrick Dale60 | 10% Owner | Sell | 1,112 | $1.58 | $1,756.96 | -0.2% | +45.6% | +4.4% | |
| Apr 9, 2024 | Silva Francisco48 | VP Of Research And Development | Buy | 8,308 | $1.23 | $10,229.32 | +1.9% | +47.7% | +43.8% | |
| Feb 9, 2024 | Broadrick Dale60 | 10% Owner | Buy | 160,000 | $1.29 | $206,022.87 | +22.5% | +5.9% | +70.4% | |
| Feb 8, 2024 | Broadrick Dale60 | 10% Owner | Buy | 120,000 | $1.35 | $162,254.96 | +17.4% | +10.9% | +79.7% | |
| Dec 1, 2023 | Broadrick Dale60 | 10% Owner | Sell | 250 | $1.88 | $469.25 | - | -24.3% | -17.3% | |
| Nov 27, 2023 | Broadrick Dale60 | 10% Owner | Sell | 278 | $1.89 | $525.42 | - | -29.5% | -21.1% | |
| Sep 15, 2023 | Alstodt Lance55 | President, CEO, Cob | Buy | 2,200 | $1.70 | $3,740.00 | +1.2% | +18.6% | +1.2% | |
| Sep 15, 2023 | Broadrick Dale60 | 10% Owner | Buy | 20,000 | $1.60 | $32,000.00 | +3.2% | +18.6% | +1.2% | |
| Sep 13, 2023 | Alstodt Lance55 | President, CEO, Cob | Buy | 800 | $1.53 | $1,226.00 | +0.4% | +22.7% | 0.0% | |
| Sep 7, 2023 | Broadrick Dale60 | 10% Owner | Buy | 2,500 | $2.07 | $5,165.00 | +0.3% | -4.3% | -19.0% |